No headlines found.
No press releases found.
No news found.
The investment objective of the FT Vest U.S. Equity Max Buffer ETF - December (the "Fund") is to seek to provide investors with returns (before fees and expenses) that match the price return of the SPDR S&P 500 ETF Trust (the "Underlying ETF") up to a predetermined upside cap while seeking to provide the maximum available buffer (before fees and expenses), against Underlying ETF losses over an approximate period of one year (the "Target Outcome Period"). Over the Target Outcome Period that began on December 23, 2024 and ends on December 19, 2025 the Fund seeks to buffer against the first 100% of Underlying ETF losses and limit gains up to a predetermined upside cap of 7.33%.When the Fund's fees and expenses are taken into account, the cap is 6.48% and the buffer is 99.15%. The Fund uses FLEX Options to employ a "target outcome strategy." Target outcome strategies seek to produce predetermined investment outcomes based upon the performance of an underlying security or index.
FT Vest US Equity Max Buffer ETF - December trades on the BATS stock market under the symbol DECM.
As of January 3, 2025, DECM stock price climbed to $30.80 with 57,754 million shares trading.
DECM has a market cap of $15.40 million. This is considered a Sub-Micro Cap stock.
DECM support price is $30.65 and resistance is $30.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DECM shares will trade within this expected range on the day.